BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30866672)

  • 1. Improving pragmatic clinical trial design using real-world data.
    Shortreed SM; Rutter CM; Cook AJ; Simon GE
    Clin Trials; 2019 Jun; 16(3):273-282. PubMed ID: 30866672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using predictive analytics to improve pragmatic trial design.
    Shortreed SM; Simon GE
    Clin Trials; 2020 Aug; 17(4):394-401. PubMed ID: 32153209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial.
    Simon GE; Beck A; Rossom R; Richards J; Kirlin B; King D; Shulman L; Ludman EJ; Penfold R; Shortreed SM; Whiteside U
    Trials; 2016 Sep; 17(1):452. PubMed ID: 27634417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The APPROACH trial: Assessing pain, patient-reported outcomes, and complementary and integrative health.
    Zeliadt SB; Coggeshall S; Thomas E; Gelman H; Taylor SL
    Clin Trials; 2020 Aug; 17(4):351-359. PubMed ID: 32522024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inclusion of real world evidence in clinical development planning.
    Martina R; Jenkins D; Bujkiewicz S; Dequen P; Abrams K;
    Trials; 2018 Aug; 19(1):468. PubMed ID: 30157904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pragmatic Clinical Trial Approach to Assessing and Monitoring Suicidal Ideation: Results from A National US Trauma Care System Study.
    Engstrom A; Moloney K; Nguyen J; Parker L; Roberts M; Moodliar R; Russo J; Wang J; Scheuer H; Zatzick D
    Psychiatry; 2022; 85(1):13-29. PubMed ID: 34932440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core.
    Cook AJ; Delong E; Murray DM; Vollmer WM; Heagerty PJ
    Clin Trials; 2016 Oct; 13(5):504-12. PubMed ID: 27179253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic wait-listed designs for randomized trials: new designs for prevention of youth suicide.
    Brown CH; Wyman PA; Guo J; Peña J
    Clin Trials; 2006; 3(3):259-71. PubMed ID: 16895043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
    Taljaard M; Goldstein CE; Giraudeau B; Nicholls SG; Carroll K; Hey SP; Brehaut JC; Jairath V; London AJ; Eldridge SM; Grimshaw JM; Fergusson DA; Weijer C
    Clin Trials; 2020 Jun; 17(3):253-263. PubMed ID: 32367741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Offering Care Management or Online Dialectical Behavior Therapy Skills Training vs Usual Care on Self-harm Among Adult Outpatients With Suicidal Ideation: A Randomized Clinical Trial.
    Simon GE; Shortreed SM; Rossom RC; Beck A; Clarke GN; Whiteside U; Richards JE; Penfold RB; Boggs JM; Smith J
    JAMA; 2022 Feb; 327(7):630-638. PubMed ID: 35166800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
    Kim SY; Flory J; Relton C
    Clin Trials; 2018 Feb; 15(1):9-16. PubMed ID: 29224380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster randomized trials utilizing primary care electronic health records: methodological issues in design, conduct, and analysis (eCRT Study).
    Gulliford MC; van Staa TP; McDermott L; McCann G; Charlton J; Dregan A;
    Trials; 2014 Jun; 15():220. PubMed ID: 24919485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP).
    Gysin-Maillart A; Schwab S; Soravia L; Megert M; Michel K
    PLoS Med; 2016 Mar; 13(3):e1001968. PubMed ID: 26930055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative Assessment and Management of Suicidality (CAMS) compared to treatment as usual (TAU) for suicidal patients: study protocol for a randomized controlled trial.
    Ryberg W; Fosse R; Zahl PH; Brorson I; Møller P; Landrø NI; Jobes D
    Trials; 2016 Oct; 17(1):481. PubMed ID: 27716298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.